Haider Mehdi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Haider Mehdi has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Barry London
Division of Cardiovascular Medicine, University of Iowa, Iowa City, Iowa, USA
4 shared publications - Jin-Young Yoon
Department of Internal Medicine, Fraternal Order of Eagles Diabetes Research Center, Abboud Cardiovascular Research Center, Carver College of Medicine (N.H.W., J.M.H., J.M.M., C.S.S., J.-Y.Y., B.L., R.L.B.), University of Iowa
2 shared publications - Kaikobad Irani
Division of Cardiovascular Medicine, University of Iowa Carver College of Medicine, Iowa City, USA
2 shared publications - Rebecca Gutmann
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA
2 shared publications - Ryan L. Boudreau
Abboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, Carver College of Medicine, University of Iowa
2 shared publications Alaa A. Shalaby
Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
1 shared publication
Latest Publications
- Open Access
Modulation of the Cardiac Sodium Channel Na V 1.5 Peak and Late Currents by NAD + Precursors
Rationale: The cardiac sodium channel Na V 1.5, encoded by SCN5A , produces the rapidly inactivating depolarizing current I Na that is responsible for the initiation and propagation of the cardiac action potential. Acquired and inherited dysfunction of Na V 1.5 results in either decreased peak I Na or increased residual late I Na (I Na,L ), leading to tachy/bradyarrhythmias and sudden cardiac death. Previous studies have shown that increased cellular NAD + and NAD + /NADH ratio increase I Na through suppression of mitochondrial reactive oxygen species and PKC-mediated Na V 1.5 phosphorylation. In addition, NAD + -dependent deacetylation of Na V 1.5 at K1479 by Sirtuin 1 increases Na V 1.5 membrane trafficking and I Na . The role of NAD + precursors in modulating I Na remains unknown. Objective: To determine whether and by which mechanisms the NAD + precursors nicotinamide riboside (NR) and nicotinamide (NAM) affect peak I Na and I Na,L in vitro and cardiac electrophysiology in vivo . Methods and Results: The effects of NAD + precursors on the NAD + metabolome and electrophysiology were studied using HEK293 cells expressing wild-type and mutant Na V 1.5, rat neonatal cardiomyocytes (RNCMs), and mice. NR increased I Na in HEK293 cells expressing Na V 1.5 (500 μM: 51 ± 18%, p=0.02, 5 mM: 59 ± 22%, p=0.03) and RNCMs (500 µM: 60 ± 26%, p=0.02, 5 mM: 75 ± 39%, p=0.03) while reducing I Na,L at the higher concentration (RNCMs, 5 mM: −45 ± 11%, p=0.04). NR (5 mM) decreased Na V 1.5 K1479 acetylation but increased I Na in HEK293 cells expressing a mutant form of Na V 1.5 with disruption of the acetylation site (Na V 1.5-K1479A). Disruption of the PKC phosphorylation site abolished the effect of NR on I Na . Furthermore, NAM (5 mM) had no effect on I Na in RNCMs or in HEK293 cells expressing wild-type Na V 1.5, but increased I Na in HEK293 cells expressing Na V 1.5-K1479A. Dietary supplementation with NR for 10-12 weeks decreased QTc in C57BL/6J mice (0.35% NR: −4.9 ± 2.0%, p=0.26; 1.0% NR: −9.5 ± 2.8%, p=0.01). Conclusions: NAD + precursors differentially regulate Na V 1.5 via multiple mechanisms. NR increases I Na , decreases I Na,L , and warrants further investigation as a potential therapy for arrhythmic disorders caused by Na V 1.5 deficiency and/or dysfunction.
Open AccessModulation of the Cardiac Sodium Channel Na V 1.5 Peak and Late Currents by NAD + Precursors
Rationale: The cardiac sodium channel Na V 1.5, encoded by SCN5A , produces the rapidly inactivating depolarizing current I Na that is responsible for the initiation and propagation of the cardiac action potential. Acquired and inherited dysfunction of Na V 1.5 results in either decreased peak I Na or increased residual late I Na (I Na,L ), leading to tachy/bradyarrhythmias and sudden cardiac death. Previous studies have shown that increased cellular NAD + and NAD + /NADH ratio increase I Na through suppression of mitochondrial reactive oxygen species and PKC-mediated Na V 1.5 phosphorylation. In addition, NAD + -dependent deacetylation of Na V 1.5 at K1479 by Sirtuin 1 increases Na V 1.5 membrane trafficking and I Na . The role of NAD + precursors in modulating I Na remains unknown. Objective: To determine whether and by which mechanisms the NAD + precursors nicotinamide riboside (NR) and nicotinamide (NAM) affect peak I Na and I Na,L in vitro and cardiac electrophysiology in vivo . Methods and Results: The effects of NAD + precursors on the NAD + metabolome and electrophysiology were studied using HEK293 cells expressing wild-type and mutant Na V 1.5, rat neonatal cardiomyocytes (RNCMs), and mice. NR increased I Na in HEK293 cells expressing Na V 1.5 (500 μM: 51 ± 18%, p=0.02, 5 mM: 59 ± 22%, p=0.03) and RNCMs (500 µM: 60 ± 26%, p=0.02, 5 mM: 75 ± 39%, p=0.03) while reducing I Na,L at the higher concentration (RNCMs, 5 mM: −45 ± 11%, p=0.04). NR (5 mM) decreased Na V 1.5 K1479 acetylation but increased I Na in HEK293 cells expressing a mutant form of Na V 1.5 with disruption of the acetylation site (Na V 1.5-K1479A). Disruption of the PKC phosphorylation site abolished the effect of NR on I Na . Furthermore, NAM (5 mM) had no effect on I Na in RNCMs or in HEK293 cells expressing wild-type Na V 1.5, but increased I Na in HEK293 cells expressing Na V 1.5-K1479A. Dietary supplementation with NR for 10-12 weeks decreased QTc in C57BL/6J mice (0.35% NR: −4.9 ± 2.0%, p=0.26; 1.0% NR: −9.5 ± 2.8%, p=0.01). Conclusions: NAD + precursors differentially regulate Na V 1.5 via multiple mechanisms. NR increases I Na , decreases I Na,L , and warrants further investigation as a potential therapy for arrhythmic disorders caused by Na V 1.5 deficiency and/or dysfunction.
- Open Access
- 29 January 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (3) , 1154-1163
A common variant alters SCN5A–miR-24 interaction and associates with heart failure mortality
SCN5A encodes the voltage-gated Na+ channel NaV1.5 that is responsible for depolarization of the cardiac action potential and rapid intercellular conduction. Mutations disrupting the SCN5A coding sequence cause inherited arrhythmias and cardiomyopathy, and single-nucleotide polymorphisms (SNPs) linked to SCN5A splicing, localization, and function associate with heart failure–related sudden cardiac death. However, the clinical relevance of SNPs that modulate SCN5A expression levels remains understudied. We recently generated a transcriptome-wide map of microRNA (miR) binding sites in human heart, evaluated their overlap with common SNPs, and identified a synonymous SNP (rs1805126) adjacent to a miR-24 site within the SCN5A coding sequence. This SNP was previously shown to reproducibly associate with cardiac electrophysiological parameters, but was not considered to be causal. Here, we show that miR-24 potently suppresses SCN5A expression and that rs1805126 modulates this regulation. We found that the rs1805126 minor allele associates with decreased cardiac SCN5A expression and that heart failure subjects homozygous for the minor allele have decreased ejection fraction and increased mortality, but not increased ventricular tachyarrhythmias. In mice, we identified a potential basis for this in discovering that decreased Scn5a expression leads to accumulation of myocardial reactive oxygen species. Together, these data reiterate the importance of considering the mechanistic significance of synonymous SNPs as they relate to miRs and disease, and highlight a surprising link between SCN5A expression and nonarrhythmic death in heart failure.
- 29 January 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (3) , 1154-1163
Open AccessA common variant alters SCN5A–miR-24 interaction and associates with heart failure mortality
SCN5A encodes the voltage-gated Na+ channel NaV1.5 that is responsible for depolarization of the cardiac action potential and rapid intercellular conduction. Mutations disrupting the SCN5A coding sequence cause inherited arrhythmias and cardiomyopathy, and single-nucleotide polymorphisms (SNPs) linked to SCN5A splicing, localization, and function associate with heart failure–related sudden cardiac death. However, the clinical relevance of SNPs that modulate SCN5A expression levels remains understudied. We recently generated a transcriptome-wide map of microRNA (miR) binding sites in human heart, evaluated their overlap with common SNPs, and identified a synonymous SNP (rs1805126) adjacent to a miR-24 site within the SCN5A coding sequence. This SNP was previously shown to reproducibly associate with cardiac electrophysiological parameters, but was not considered to be causal. Here, we show that miR-24 potently suppresses SCN5A expression and that rs1805126 modulates this regulation. We found that the rs1805126 minor allele associates with decreased cardiac SCN5A expression and that heart failure subjects homozygous for the minor allele have decreased ejection fraction and increased mortality, but not increased ventricular tachyarrhythmias. In mice, we identified a potential basis for this in discovering that decreased Scn5a expression leads to accumulation of myocardial reactive oxygen species. Together, these data reiterate the importance of considering the mechanistic significance of synonymous SNPs as they relate to miRs and disease, and highlight a surprising link between SCN5A expression and nonarrhythmic death in heart failure.
- 31 March 2012
- Published by Elsevier in Heart Rhythm
- Vol. 9 (3) , 399-404
Cardiac levels of NOS1AP RNA from right ventricular tissue recovered during lead extraction
- 31 March 2012
- Published by Elsevier in Heart Rhythm
- Vol. 9 (3) , 399-404
Cardiac levels of NOS1AP RNA from right ventricular tissue recovered during lead extraction